Supply Issues Becton Dickinson UK Ltd Hypodermic Syringe FWC244 (ICN 2776)

• The supply issue with Hypodermic Syringe products from Becton Dickinson UK Ltd is continuing.
• One product code remains suspended and unavailable to order:
  • FWC244 – Hypodermic Syringe 3ml Luer Lock 3 Piece Concentric Clear Sterile.
• One product code remains affected in total.
• Potential indirect alternative products are available to order through our online catalogue:
  • FWC196 – Hypodermic Syringe 2 to 3ml Luer Lock Concentric Clear Plunger Sterile
  • FWC339 – Hypodermic Syringe 3ml Luer Lock 3 Piece Concentric Clear Sterile
  • FWC700 – Hypodermic Syringe 3ml Luer Slip 3 Piece Concentric clear Sterile
  • FWC701 – Hypodermic Syringe 3ml Luer Lock 3 Piece Concentric clear Sterile.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is now anticipated to be resolved by 17 February 2025.

Change:

• The supplier Becton Dickinson UK Ltd Stock Oxford has informed us of a supply issue with its Hypodermic Syringe products.
• One product code is affected in total:
  • FWC244 – Hypodermic Syringe 3ml Luer Lock 3 Piece Concentric Clear Sterile.
• The supply issue is due to increased demand and lead times.

Impact:

• The affected product is currently suspended and unavailable to order.
• Potential indirect alternative products are available to order through our online catalogue:
• • FWC196 – Hypodermic Syringe 2 to 3ml Luer Lock Concentric Clear Plunger Sterile
  • FWC339 – Hypodermic Syringe 3ml Luer Lock 3 Piece Concentric Clear Sterile
  • FWC700 – Hypodermic Syringe 3ml Luer Slip 3 Piece Concentric clear Sterile
  • FWC701 – Hypodermic Syringe 3ml Luer Lock 3 Piece Concentric clear Sterile.
• Customers are advised to consider the possible size differences when seeking potential alternatives.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 10 January 2025.

Next Steps:               

• Customers are advised to log into our website to view the product listing for further information on the affected product code and potential alternatives.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.